The original viibryd dose level can be resumed when the cyp3a4 inhibitor is discontinued see drug interactions.
Viibryd dosage range.
Viibryd starting dose is typically 10 mg orally once a day for 7 days followed by 20 mg orally once a day for an additional 7 days maintenance dose is 20 40 mg orally once a day.
Latuda has been shown to be effective in a dose range of 20 mg per day to 80 mg per day as monotherapy.
Patients receiving concomitant cyp3a4 inducers based on clinical response consider increasing the dosage of viibryd by 2 fold up to a maximum 80 mg once daily over 1 to 2 weeks in patients taking strong cyp3a4 inducers e g.
Patients receiving concomitant cyp3a4 inducers.
At the end of the clinical study most of the patients 67 received 20 mg or 40 mg once daily see clinical studies.
Follow by reducing dose to 10 mg qday for 3 days.
If patient is taking 20 mg day taper dose to 10 mg qday for 7 days.
Start with an initial dosage of 10 mg once daily with food for 7 days.
Take viibryd with food.
Based on clinical response consider increasing the dosage of viibryd by 2 fold up to a maximum 80 mg once daily over 1 to 2 weeks in patients taking strong cyp3a4 inducers e g.
Patients receiving concomitant cyp3a4 inducers.
The original viibryd dose level can be resumed when the cyp3a4 inhibitor is discontinued see drug interactions.
The maximum recommended dose is 80 mg per day.
Most likely your doctor will start you with a 10 mg dose once daily for 7 days.
A drug called viibryd vilazodone promises to provide relief with fewer adverse effects and clinical studies suggest that it s significantly less likely to cause weight gain and sexual dysfunction two side effects that often lead people to go off of other antidepressants.
The original viibryd dose level can be resumed when the cyp3a4 inhibitor is discontinued.
In patients taking 40 mg day taper dose to 20 mg qday for 4 ddays.
2 1 dosage for treatment of major depressive disorder the recommended target dosage for viibryd is 20 mg to 40 mg orally once daily with food see clinical pharmacology 12 3 clinical studies 14.
Based on clinical response consider increasing the dosage of viibryd by 2 fold up to a maximum 80 mg once daily over 1 to 2 weeks in patients taking strong cyp3a4 inducers e g.
Viibryd comes in 10 mg 20 mg and 40 mg tablets.
To achieve the target dosage titrate viibryd as follows.
The viibryd dose should not exceed 20 mg once daily if co administered with strong cyp3a4 inhibitors eg itraconazole clarithromycin voriconazole.
Gradually taper dose upon discontinuation of antidepressant to minimize withdrawal symptoms and allow for detection of re emerging symptoms.
